2-(3,5-dimethoxyphenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine

Catalog No. :
ACTOKE412
CAS No. :
2126948-42-1
Molecular Formula :
C18H17BN2O2
Molecular Weight :
304.16

IUPAC Name:2-(3,5-dimethoxyphenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine

2-(3,5-dimethoxyphenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3,5-dimethoxyphenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine
IUPAC Name2-(3,5-dimethoxyphenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine
Molecular FormulaC18H17BN2O2
Molecular Weight304.16
SMILESCOC1=CC(OC)=CC(B2NC3=C4C(N2)=CC=CC4=CC=C3)=C1
InChI KeyQWHJCELPUHSBGP-UHFFFAOYSA-N
Synonym2-(3,5-Dimethoxyphenyl)-2,3-dihydro-1H-naphtho[1,8-de]-1,3,2-diazaborine;1H-Naphtho[1,8-de]-1,3,2-diazaborine, 2-(3,5-dimethoxyphenyl)-2,3-dihydro-;2-(3,5-Dimethoxyphenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine
CAS No.2126948-42-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTOKE412 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACERXV708 route compound structure diagram
    ACERXV708192182-54-0 In Stock
  2. Plus
  3. ACRMJN620 route compound structure diagram
    ACRMJN6202973762-38-6 In Stock
  4. Then
  5. ACTOKE412 route product structure diagram
    ACTOKE4122126948-42-1
Inquiry

2. ACTOKE412 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTOKE412 route product structure diagram
    ACTOKE4122126948-42-1
Inquiry

Comments (0)